Alec Stranahan is a Senior Analyst in Equity Research focusing on US Small- and Mid-Cap Biotechnology. He has been with the firm since 2018. Stranahan earned his Ph.D in Molecular Biology at Weill Cornell Medicine and an MBA from the Cornell SC Johnson College of Business. He has a BS degree in Molecular Genetics from the University of Vermont. Stranahan is based in New York.